ATG14 and type 1 diabetes mellitus: Regarding the main markers for the autophagy pathway, we have observed increased expression of some of these markers, where Beclin1 (p = 0.0029), Atg5 (p = 0.0101), and Atg7 (p = 0.0012)from 129sve T1D mice treated with Cap were increased compared to the Wt group, while both 129sve T1D mice showed increased Atg14 (Wt vs T1D p = 0.0117; Wt vs T1D + Cap p = 0.0001) and LC3 (Wt vs T1D p = 0.0062; Wt vs T1D + Cap p < 0.0001) expression regardless of Cap treatment, compared to the Wt group (Fig. 8A, C, E, G, I, K).